← Back to headlines
Annexon Biosciences (ANNX) Stock Retains Buy Rating
Financial analysts have reaffirmed a "Buy" rating for Annexon Biosciences (ANNX) stock. This indicates continued confidence in the company's financial prospects and investment potential.
21 Apr, 21:14 — 21 Apr, 21:14
Sources
Showing 1 of 1 sources
Related Stories
Volkswagen Group Reportedly Plans to Phase Out Seat Brand by 2029
21m ago
Discovery Reports Strong Annual Earnings Driven by Banking Growth and AI Initiatives
36m ago
Telangana Chief Minister Dismisses Forest Minister Following Family Controversy
36m ago
China Urges France to Suspend Fast-Fashion Law Amid Threat of Trade Retaliation
58m ago